Previous studies have shown that SRSF1, predominantly driven by Myc, is highly expressed in multiple types of human cancer, including gliomas, and serves as an oncogenic factor via oncogenic splice-switching of MYO1B 39, 40. This evidence concerns the gene MYC and central nervous system cancer.